File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective

TitleDirect medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective
Authors
KeywordsChinese
Colorectal neoplasm
Cost-of-illness
Direct medical cost
Health care service provider
Service utilization
Issue Date2012
Citation
Journal Of Evaluation In Clinical Practice, 2012, v. 18 n. 6, p. 1203-1210 How to Cite?
AbstractObjectives To estimate the direct medical cost of colorectal neoplasia (CRN) from newly diagnosed to the completion of the tumour-specific treatment in the initial year of disease across stages and tumour primary sites. Methods Only direct medical costs from the perspective of the health care service provider were incorporated in the cost analysis (in 2009 USD) using a bottom-up approach. Tumour-specific treatments of surgery, chemotherapy and radiotherapy data in the initial year of disease were identified from the 401 CRN adult patients by a review of their medical records. Service utilization for diagnosis, staging, pre-operative assessment and post-operative follow-up consultations was estimated from the recommendations of established surveillance and clinical practice guidelines. Results Direct medical cost for the care of a newly diagnosed CRN was ranging from $1941 for low-risk polyp to $45115 for stage IV colorectal cancer in the initial year of care. Costs of care showed a gradient increase from $1748 for low-risk colonic polyps to $42899 for stage IV colon cancer, and from $2232 for low-risk rectal polyps to $48453 for stage IV rectal cancers. Diagnostic/pre-operative assessment and treatment accounted for most of total costs of colorectal polyp (58.9-76.7%) and cancer (60.8-85.2%) care. Conclusion The results provided stage and site-specific estimations of the direct medical costs of CRN in a Chinese population that can assist policy decision making and facilitate health care service planning and cost-effectiveness evaluations. © 2011 Blackwell Publishing Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/150842
ISSN
2015 Impact Factor: 1.053
2015 SCImago Journal Rankings: 0.730
ISI Accession Number ID
Grants

 

DC FieldValueLanguage
dc.contributor.authorWong, CKHen_HK
dc.contributor.authorLam, CLKen_HK
dc.contributor.authorPoon, JTCen_HK
dc.contributor.authorMcghee, SMen_HK
dc.contributor.authorLaw, WLen_HK
dc.contributor.authorKwong, DLWen_HK
dc.contributor.authorTsang, Jen_HK
dc.contributor.authorChan, Pen_HK
dc.date.accessioned2012-06-26T06:12:06Z-
dc.date.available2012-06-26T06:12:06Z-
dc.date.issued2012en_HK
dc.identifier.citationJournal Of Evaluation In Clinical Practice, 2012, v. 18 n. 6, p. 1203-1210en_HK
dc.identifier.issn1356-1294en_HK
dc.identifier.urihttp://hdl.handle.net/10722/150842-
dc.description.abstractObjectives To estimate the direct medical cost of colorectal neoplasia (CRN) from newly diagnosed to the completion of the tumour-specific treatment in the initial year of disease across stages and tumour primary sites. Methods Only direct medical costs from the perspective of the health care service provider were incorporated in the cost analysis (in 2009 USD) using a bottom-up approach. Tumour-specific treatments of surgery, chemotherapy and radiotherapy data in the initial year of disease were identified from the 401 CRN adult patients by a review of their medical records. Service utilization for diagnosis, staging, pre-operative assessment and post-operative follow-up consultations was estimated from the recommendations of established surveillance and clinical practice guidelines. Results Direct medical cost for the care of a newly diagnosed CRN was ranging from $1941 for low-risk polyp to $45115 for stage IV colorectal cancer in the initial year of care. Costs of care showed a gradient increase from $1748 for low-risk colonic polyps to $42899 for stage IV colon cancer, and from $2232 for low-risk rectal polyps to $48453 for stage IV rectal cancers. Diagnostic/pre-operative assessment and treatment accounted for most of total costs of colorectal polyp (58.9-76.7%) and cancer (60.8-85.2%) care. Conclusion The results provided stage and site-specific estimations of the direct medical costs of CRN in a Chinese population that can assist policy decision making and facilitate health care service planning and cost-effectiveness evaluations. © 2011 Blackwell Publishing Ltd.en_HK
dc.languageengen_US
dc.relation.ispartofJournal of Evaluation in Clinical Practiceen_HK
dc.subjectChineseen_HK
dc.subjectColorectal neoplasmen_HK
dc.subjectCost-of-illnessen_HK
dc.subjectDirect medical costen_HK
dc.subjectHealth care service provideren_HK
dc.subjectService utilizationen_HK
dc.titleDirect medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspectiveen_HK
dc.typeArticleen_HK
dc.identifier.emailLam, CLK:clklam@hku.hken_HK
dc.identifier.emailPoon, JTC:tcjensen@hkucc.hku.hken_HK
dc.identifier.emailMcghee, SM:smmcghee@hkucc.hku.hken_HK
dc.identifier.emailLaw, WL:lawwl@hkucc.hku.hken_HK
dc.identifier.emailKwong, DLW:dlwkwong@hku.hken_HK
dc.identifier.emailTsang, J:jwhtsang@hku.hken_HK
dc.identifier.authorityLam, CLK=rp00350en_HK
dc.identifier.authorityPoon, JTC=rp01603en_HK
dc.identifier.authorityMcghee, SM=rp00393en_HK
dc.identifier.authorityLaw, WL=rp00436en_HK
dc.identifier.authorityKwong, DLW=rp00414en_HK
dc.identifier.authorityTsang, J=rp00278en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1365-2753.2011.01776.xen_HK
dc.identifier.pmid22111837-
dc.identifier.scopuseid_2-s2.0-84868194454en_HK
dc.identifier.hkuros200931-
dc.identifier.hkuros205691-
dc.identifier.isiWOS:000310487300013-
dc.publisher.placeUnited Kingdomen_HK
dc.relation.projectA Study on Health-related Quality of Life of patients with Colorectal Neoplasm and Cost-Effectiveness Analysis of Colorectal Cancer Screening in Hong Kong-
dc.identifier.scopusauthoridWong, CKH=36465969200en_HK
dc.identifier.scopusauthoridLam, CLK=24755913900en_HK
dc.identifier.scopusauthoridPoon, JTC=7005903722en_HK
dc.identifier.scopusauthoridMcghee, SM=7003288588en_HK
dc.identifier.scopusauthoridLaw, WL=7103147867en_HK
dc.identifier.scopusauthoridKwong, DLW=15744231600en_HK
dc.identifier.scopusauthoridTsang, J=35141929400en_HK
dc.identifier.scopusauthoridChan, P=47661052600en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats